Hepatitis E future or investigational therapies

Hepatitis E Microchapters
Home
Patient Information
Overview
Historical Perspective
Pathophysiology
Causes
Epidemiology and Demographics
Risk Factors
Screening
Differentiating Hepatitis E from other Diseases
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Treatment
Medical Therapy
Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Hepatitis E future or investigational therapies On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Hepatitis E future or investigational therapies All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Hepatitis E future or investigational therapies
CDC on Hepatitis E future or investigational therapies
Hepatitis E future or investigational therapies in the news
Blogs on Hepatitis E future or investigational therapies
Directions to Hospitals Treating Hepatitis E
Risk calculators and risk factors for Hepatitis E future or investigational therapies

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: João André Alves Silva, M.D. [2]

Overview

Attending to the impact of hepatitis E worldwide, further studies are required to diagnose and treat severe cases of the disease. Patients with elevated liver transaminases, particularly immunocompromised and end-stage liver disease patients should be tested for the presence of HEV RNA. Infected pregnant women also have an increased risk of complications, and should be tested and treated as well.

Further studies are required to answer questions such as: